Literature DB >> 24468671

Absence of in vitro genotoxicity potential of the mycotoxin deoxynivalenol in bacteria and in human TK6 and HepaRG cell lines.

Natsuko Takakura1, Fabrice Nesslany2, Valérie Fessard3, Ludovic Le Hegarat4.   

Abstract

Deoxynivalenol (DON) is the major mycotoxin detected in cereal foods and a risk for human health following DON ingestion could not be excluded due to high level exposure. In this light, the hazard of DON must be carefully evaluated. Therefore, the aim of this study is to perform in vitro genotoxicity tests with DON using the Salmonella typhimurium reverse mutation assay (Ames' test), the comet assay and the micronucleus test in accordance with the OECD test guideline 487 in two human cell lines: the lymphoblastoid TK6 and the hepatoma HepaRG cells. DON gave negative results in the Ames' test performed, both with and without rat liver S9 on three strains TA98, TA100 and TA102. DON elicited cytotoxicity in TK6 and HepaRG cells but did not induce primary DNA damage. DON failed also to induce MN formation in TK6 cells with or without human and rat liver S9. After 24h of treatment, DON induced micronucleus formation in TK6 cells but only at concentrations producing more than 55 ± 5% cytotoxicity. In HepaRG cells, DON highly increased the caspase-3/7 activity but no micronucleus induction was observed. Taken together, our results suggest that DON could be considered as a non in vitro genotoxin.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Comet; Deoxynivalenol; Genotoxicity; HepaRG; Micronucleus; TK6

Mesh:

Substances:

Year:  2014        PMID: 24468671     DOI: 10.1016/j.fct.2014.01.029

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Genotoxicity of 12 Mycotoxins by the SOS/umu Test: Comparison of Liver and Kidney S9 Fraction.

Authors:  Maria Alonso-Jauregui; Elena González-Peñas; Adela López de Cerain; Ariane Vettorazzi
Journal:  Toxins (Basel)       Date:  2022-06-10       Impact factor: 5.075

Review 2.  A novel Peptide-binding motifs inference approach to understand deoxynivalenol molecular toxicity.

Authors:  Yousef I Hassan; Christena Watts; Xiu-Zhen Li; Ting Zhou
Journal:  Toxins (Basel)       Date:  2015-06-02       Impact factor: 4.546

3.  In Silico and In Vitro Studies of Mycotoxins and Their Cocktails; Their Toxicity and Its Mitigation by Silibinin Pre-Treatment.

Authors:  Van Nguyen Tran; Jitka Viktorova; Katerina Augustynkova; Nikola Jelenova; Simona Dobiasova; Katerina Rehorova; Marie Fenclova; Milena Stranska-Zachariasova; Libor Vitek; Jana Hajslova; Tomas Ruml
Journal:  Toxins (Basel)       Date:  2020-02-28       Impact factor: 4.546

4.  Prioritization of Mycotoxins Based on Their Genotoxic Potential with an In Silico-In Vitro Strategy.

Authors:  Maria Alonso-Jauregui; María Font; Elena González-Peñas; Adela López de Cerain; Ariane Vettorazzi
Journal:  Toxins (Basel)       Date:  2021-10-19       Impact factor: 4.546

5.  Oral deoxynivalenol toxicity in Harlan Sprague Dawley (Hsd:Sprague Dawley® SD®) rat dams and their offspring.

Authors:  Madelyn C Huang; Johnathan R Furr; Veronica G Robinson; Laura Betz; Keith Shockley; Helen Cunny; Kristine Witt; Suramya Waidyanatha; Dori Germolec
Journal:  Food Chem Toxicol       Date:  2020-12-31       Impact factor: 6.023

6.  Risk Assessment of Deoxynivalenol by Revisiting Its Bioavailability in Pig and Rat Models to Establish Which Is More Suitable.

Authors:  Manuel Jimmy Saint-Cyr; Agnès Perrin-Guyomard; Jacqueline Manceau; Paméla Houée; Jean-Michel Delmas; Jean-Guy Rolland; Michel Laurentie
Journal:  Toxins (Basel)       Date:  2015-12-01       Impact factor: 4.546

7.  Understanding the Bacterial Response to Mycotoxins: The Transcriptomic Analysis of Deoxynivalenol-Induced Changes in Devosia mutans 17-2-E-8.

Authors:  Yousef I Hassan; Jian Wei He; Dion Lepp; Ting Zhou
Journal:  Front Pharmacol       Date:  2019-11-14       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.